A confusing case of canine vector-borne disease: clinical signs and progression in a dog co-infected with Ehrlichia canis and Bartonella vinsonii ssp. berkhoffii

Bartonella spp. are important pathogens in human and veterinary medicine, and bartonellosis is considered as an emerging zoonosis that is being reported with increasing frequency. Of 22 known species and subspecies of Bartonella, seven have been isolated from dogs, causing disease manifestations similar to those seen in human beings. The wide variety of clinical signs and the possible chronic progression of disease manifestations are illustrated in the case of an infected Labrador retriever. Here, the authors discuss the seemingly diverse spectrum of disease manifestations, the co-infections of Bartonella spp. with other vector-borne pathogens (mainly Ehrlichia spp. or Babesia spp.) and the difficulties in microbiological confirmation of an active Bartonella infection, all of which make the disease pathogenesis and clinical diagnosis more problematic

Isolation of Candidatus Bartonella melophagi from Human Blood1

Candidatus Bartonella melophagi was isolated by blood culture from 2 women, 1 of whom was co-infected with B. henselae. Partial 16S rRNA, RNA polymerase B, and citrate synthase genes and 16S–23S internal transcribed spacer sequences indicated that human isolates were similar to Candidatus B. melophagi

Case report: Substantial improvement of autism spectrum disorder in a child with learning disabilities in conjunction with treatment for poly-microbial vector borne infections

Poly-microbial vector-borne infections may have contributed to neuropsychiatric symptoms in a boy diagnosed with autism spectrum disorder. Targeted antimicrobial treatment resulted in substantial improvement in cognitive (such as learning disabilities, focus, concentration) and neurobehavioral (such as oppositional, defiant, anti-social, disordered mood, immaturity, tics) symptoms

Hemotropic mycoplasmas in little brown bats (Myotis lucifugus).

BackgroundHemotropic mycoplasmas are epicellular erythrocytic bacteria that can cause infectious anemia in some mammalian species. Worldwide, hemotropic mycoplasmas are emerging or re-emerging zoonotic pathogens potentially causing serious and significant health problems in wildlife. The objective of this study was to determine the molecular prevalence of hemotropic Mycoplasma species in little brown bats (Myotis lucifugus) with and without Pseudogymnoascus (Geomyces) destrucans, the causative agent of white nose syndrome (WNS) that causes significant mortality events in bats.MethodsIn order to establish the prevalence of hemotropic Mycoplasma species in a population of 68 little brown bats (Myotis lucifugus) with (n = 53) and without (n = 15) white-nose syndrome (WNS), PCR was performed targeting the 16S rRNA gene.ResultsThe overall prevalence of hemotropic Mycoplasmas in bats was 47%, with similar (p = 0.5725) prevalence between bats with WNS (49%) and without WNS (40%). 16S rDNA sequence analysis (~1,200 bp) supports the presence of a novel hemotropic Mycoplasma species with 91.75% sequence homology with Mycoplasma haemomuris. No differences were found in gene sequences generated from WNS and non-WNS animals.ConclusionsGene sequences generated from WNS and non-WNS animals suggest that little brown bats could serve as a natural reservoir for this potentially novel Mycoplasma species. Currently, there is minimal information about the prevalence, host-specificity, or the route of transmission of hemotropic Mycoplasma spp. among bats. Finally, the potential role of hemotropic Mycoplasma spp. as co-factors in the development of disease manifestations in bats, including WNS in Myotis lucifugus, remains to be elucidated

Potential for Tick-borne Bartonelloses

Although possible, tick transmission to a vertebrate host has not been proven

Candidatus Bartonella merieuxii, a potential new zoonotic Bartonella species in canids from Iraq.

Bartonellae are emerging vector-borne pathogens infecting erythrocytes and endothelial cells of various domestic and wild mammals. Blood samples were collected from domestic and wild canids in Iraq under the United States Army zoonotic disease surveillance program. Serology was performed using an indirect immunofluorescent antibody test for B. henselae, B. clarridgeiae, B. vinsonii subsp. berkhoffii and B. bovis. Overall seroprevalence was 47.4% in dogs (n = 97), 40.4% in jackals (n = 57) and 12.8% in red foxes (n = 39). Bartonella species DNA was amplified from whole blood and representative strains were sequenced. DNA of a new Bartonella species similar to but distinct from B. bovis, was amplified from 37.1% of the dogs and 12.3% of the jackals. B. vinsonii subsp. berkhoffii was also amplified from one jackal and no Bartonella DNA was amplified from foxes. Adjusting for age, the odds of dogs being Bartonella PCR positive were 11.94 times higher than for wild canids (95% CI: 4.55-31.35), suggesting their role as reservoir for this new Bartonella species. This study reports on the prevalence of Bartonella species in domestic and wild canids of Iraq and provides the first detection of Bartonella in jackals. We propose Candidatus Bartonella merieuxii for this new Bartonella species. Most of the Bartonella species identified in sick dogs are also pathogenic for humans. Therefore, seroprevalence in Iraqi dog owners and bacteremia in Iraqi people with unexplained fever or culture negative endocarditis requires further investigation as well as in United States military personnel who were stationed in Iraq. Finally, it will also be essential to test any dog brought back from Iraq to the USA for presence of Bartonella bacteremia to prevent any accidental introduction of a new Bartonella species to the New World

Serological evidence of exposure to Rickettsia, Bartonella and Ehrlichia spp. in healthy or Leishmania infantum infected dogs from Barcelona

Fifty dogs from the area around Barcelona, Spain, were evaluated for serologic evidence of exposure to vector-borne pathogens. Dirofilaria immitis, Ehrlichiacanis, Borrelia burgdorferi, Leishmania infantum, Bartonella vinsonii subspecies berkhoffi, and Rickettsia rickettsii antigens were used for testing purposes. Seroreactivity was determined in 3 different groups of dogs that were categorized based upon their L infantum infection status: uninfected healthy dogs (group 1), L infantum-infected healthy dogs (group 2), and L infantum-infected dogs with clinical manifestations consistent with leishmaniasis (group 3). Of the 50 dogs included in this study, 49 had serologic evidence of exposure to at least 1 organism for which testing was performed

Bartonella quintana Endocarditis in Dogs

TOC summary line: PCR and sequencing provide the first evidence that B. quintana can be pathogenic in dogs

PCR amplification of Bartonella koehlerae from human blood and enrichment blood cultures

<p>Abstract</p> <p>Background</p> <p>Cats appear to be the primary reservoir host for <it>Bartonella koehlerae</it>, an alpha Proteobacteria that is most likely transmitted among cat populations by fleas (<it>Ctenocephalides felis</it>). <it>Bartonella koehlerae </it>has caused endocarditis in a dog and in one human patient from Israel, but other clinically relevant reports involving this bacterium are lacking. Despite publication of numerous, worldwide epidemiological studies designed to determine the prevalence of <it>Bartonella </it>spp. bacteremia in cats, <it>B. koehlerae </it>has never been isolated using conventional blood agar plates. To date, successful isolation of <it>B. koehlerae </it>from cats and from the one human endocarditis patient has consistently required the use of chocolate agar plates.</p> <p>Results</p> <p>In this study, <it>Bartonella koehlerae </it>bacteremia was documented in eight immunocompetent patients by PCR amplification and DNA sequencing, either prior to or after enrichment blood culture using <it>Bartonella </it>alpha Proteobacteria growth medium. Presenting symptoms most often included fatigue, insomnia, joint pain, headache, memory loss, and muscle pain. Four patients were also infected with <it>Bartonella vinsonii </it>subsp. <it>berkhoffii </it>genotype II. After molecular documentation of <it>B. koehlerae </it>infection in these patients, a serological test was developed and serum samples were tested retrospectively. <it>Bartonella koehlerae </it>antibodies were not detected (titers < 1:16) in 30 healthy human control sera, whereas five of eight patient samples had <it>B. koehlerae </it>antibody titers of 1:64 or greater.</p> <p>Conclusions</p> <p>Although biased by a study population consisting of individuals with extensive arthropod and animal exposure, the results of this study suggest that <it>B. koehlerae </it>bacteremia is more common in immunocompetent people than has been previously suspected. Future studies should more thoroughly define modes of transmission and risk factors for acquiring infection with <it>B. koehlerae</it>. In addition, studies are needed to determine if <it>B. koehlerae </it>is a cause or cofactor in the development of arthritis, peripheral neuropathies or tachyarrhythmias in patients.</p